U.S. Consumer Durables Stock News

NasdaqGS:NWPX
NasdaqGS:NWPXConstruction

Does NWPX (NWPX)ʼs First Curved RBJ Pipeline Win Hint at a Durable Trenchless Moat?

In January 2026, NWPX Infrastructure announced the first commercial use of its patent-pending Permalok Radial Bending Joint (RBJ) technology, supplying 5,764 linear feet of curved steel casing pipe for Tampa Bay Water’s South Hillsborough Pipeline microtunneling project, which includes 18 underground crossings. This curved RBJ system enables pipeline routes to bend around existing utilities and structures, potentially lowering construction disruption through fewer shafts, smaller sites, and...
NasdaqGS:UPB
NasdaqGS:UPBBiotechs

Why Upstream Bio (UPB) Is Up 12.2% After JPM Debut And VALINAT Hopes

In early January 2026, Upstream Bio, Inc. presented at the 44th Annual J.P. Morgan Healthcare Conference, while analysts initiated and upgraded coverage around its asthma candidate verekitug and the upcoming Phase 2 VALINAT readout. The combination of growing physician enthusiasm for long-acting TSLP inhibition and expectations for the VALINAT data has sharpened investor focus on Upstream Bio’s clinical pipeline. Against this backdrop, we’ll examine how physician interest in verekitug and...
NasdaqGS:GLXY
NasdaqGS:GLXYCapital Markets

Galaxy Digital (GLXY) Is Up 25.5% After Doubling ERCOT-Approved Power At Helios AI Campus

On January 15, 2026, Galaxy Digital Inc. announced it had completed ERCOT’s Large Load Interconnection Study and secured approval for an additional 830 megawatts of computing demand at its Helios data center campus in West Texas, lifting total approved and contracted power capacity at the site to over 1.6 gigawatts. This substantial power upgrade underpins Galaxy’s ambition to build a multi-tenant, multi-campus, multi-gigawatt platform for AI and high-performance computing workloads, using...
NYSE:FUL
NYSE:FULChemicals

H.B. Fuller (FUL) Margin Improvement And 16.2% Earnings Growth Test Bullish Narratives

H.B. Fuller FY 2025 earnings snapshot H.B. Fuller (FUL) has wrapped up FY 2025 with fourth quarter revenue of US$894.8 million and basic EPS of US$0.55, setting the tone for a year where earnings momentum and margin progression were in focus for investors. The company has seen quarterly revenue move from US$917.9 million in Q3 2024 to the US$788.7 million to US$898.1 million range across the first three quarters of 2025, while basic EPS shifted from US$1.01 in Q3 2024 to US$0.24, US$0.77 and...
NasdaqGM:AIRO
NasdaqGM:AIROAerospace & Defense

A Look At AIRO Group Holdings (AIRO) Valuation After Liquidity Update And Upcoming Execution Milestones

Why AIRO Group Holdings (AIRO) Is Back on Investors’ Radar Recent coverage around AIRO Group Holdings (AIRO) has zeroed in on its liquidity position and upcoming execution milestones, which together help explain the renewed interest you might be seeing in the stock. See our latest analysis for AIRO Group Holdings. After a sharp 71.65% 30 day share price return and a 42.86% year to date share price return, AIRO’s recent pullback, including a 24.57% 90 day share price decline and softer 1 day...
NasdaqGS:MRCY
NasdaqGS:MRCYAerospace & Defense

Is Mercury Systems (MRCY) Pricing Reflect Its Rapid 1 Year Share Price Surge

If you are wondering whether Mercury Systems' recent share price strength still leaves any value on the table, this breakdown is designed to help you weigh the upside against the risks. The stock last closed at US$102.95, with returns of 16.0% over 7 days, 43.4% over 30 days, 35.4% year to date, 140.2% over 1 year and 119.4% over 3 years, which naturally raises questions about how the current price lines up with underlying value. These moves have played out alongside ongoing investor...
NasdaqGS:XRAY
NasdaqGS:XRAYMedical Equipment

Is Dentsply Sirona (XRAY) Pricing Reflect Recent Slide In Dental Equipment Sentiment Accurately

If you are wondering whether DENTSPLY SIRONA’s share price reflects its underlying worth, you are not alone. This article walks through what the current market price might be implying about value. The stock closed at US$12.58, with returns of 0.8% over the past week and 10.6% over the past month, set against a year to date return of 11.6% and a 1 year return of a 28.4% decline. Recent coverage has focused on how investors are reassessing dental and medical equipment names like DENTSPLY...
NYSE:IIIN
NYSE:IIINBuilding

Insteel Industries (IIIN) Net Margin Rebound Challenges Bearish Earnings Narratives

Insteel Industries (IIIN) opened its new fiscal year with Q1 2026 revenue of US$159.9 million and basic EPS of US$0.39, alongside net income of US$7.6 million. The company has seen revenue move from US$129.7 million and EPS of US$0.06 in Q1 2025 to a trailing twelve month revenue base of US$677.9 million and EPS of US$2.44. This gives investors a clearer sense of the earnings power behind the latest quarter and the improvement in net margin from 3.6% to 7% over the past year. See our full...
NYSE:J
NYSE:JProfessional Services

Is Jacobs Solutions (J) Fairly Priced After Recent Steady Multi Year Share Gains

Wondering if Jacobs Solutions at around US$141.50 is giving you fair value for the risk you take, or if the price is leaving too much on the table. The stock has seen returns of 2.2% over the last 7 days, 5.6% over 30 days, 4.5% year to date, 4.3% over 1 year, 48.1% over 3 years and 60.4% over 5 years, which naturally raises questions about how much of that performance is already reflected in the current share price. Recent news around Jacobs Solutions has focused on its role as a large US...
NasdaqGS:GLNG
NasdaqGS:GLNGOil and Gas

The Bull Case For Golar LNG (GLNG) Could Change Following Long-Term Argentina FLNG Charter Progress - Learn Why

In the past few months, Goldman Sachs began covering Golar LNG Limited with a positive view, while Golar confirmed that all Conditions Precedent for its 20‑year MKII FLNG charter with Southern Energy in Argentina had been satisfied, securing a long-term commercial arrangement. These developments, occurring against the backdrop of Argentina’s recent election of Javier Milei, meaningfully reduce policy uncertainty around the project and sharpen focus on Golar’s exposure to LNG-linked commodity...
NasdaqGS:BBSI
NasdaqGS:BBSIProfessional Services

Assessing Barrett Business Services (BBSI) Valuation After New Employee File Cabinet HR Tech Launch

What the new Employee File Cabinet launch means for BBSI shareholders Barrett Business Services (BBSI) has rolled out its Employee File Cabinet HRIS module within the BBSI Client Portal, built with Box, giving clients a secure, centralized hub for key HR documents. The launch highlights BBSI’s ongoing push to consolidate HR workflows into a single portal experience. The company points to potential benefits around compliance, time savings, and employee access to their own documents. See our...
NYSE:NRGV
NYSE:NRGVElectrical

Why Energy Vault (NRGV) Is Up 11.5% After Launching Its First ERCOT Asset Vault Project

Energy Vault Holdings, Inc. previously filed a shelf registration for US$180.55 million of common stock, while also beginning construction on the 150 MW/300 MWh SOSA Energy Center battery storage project in Madison County, Texas under its Asset Vault "Own & Operate" platform. This combination of fresh financing capacity and the company’s first Asset Vault project in the ERCOT North market highlights a shift toward owned infrastructure backed by recurring revenues and supported by a US$300...
NasdaqGS:CVGW
NasdaqGS:CVGWFood

Calavo Growers (CVGW) Margin Turnaround Challenges Cautious Earnings Narratives

Calavo Growers (CVGW) just wrapped up FY 2025 with Q4 revenue of US$124.7 million and basic EPS of US$0.21. Trailing 12 month revenue came in at US$648.4 million and EPS at US$1.11, supported by a trailing net profit margin of 3.1% versus 1.0% in the prior year. Over the last few quarters, revenue has ranged from US$154.4 million to US$190.5 million with quarterly EPS between US$0.21 and US$0.38. This points to a picture of improving profitability that puts margins, rather than top line...
NYSE:MS
NYSE:MSCapital Markets

Morgan Stanley (MS) Earnings Surge And Margin Strength Challenge Cautious Growth Narratives

Morgan Stanley (MS) has wrapped up FY 2025 with fourth quarter revenue of US$17.9b and basic EPS of US$2.72, capping a twelve month run that produced total revenue of US$70.3b and basic EPS of US$10.32, alongside a 26.9% rise in earnings and a net profit margin of 23.1% compared with 20.8% the year before. Over the past six quarters, the bank has seen quarterly revenue move from US$15.3b in Q3 2024 to US$17.9b in Q4 2025, while quarterly basic EPS moved from US$1.91 to US$2.72. This set up a...
NasdaqGM:AXSM
NasdaqGM:AXSMPharmaceuticals

Assessing Axsome Therapeutics (AXSM) After An 86% One-Year Share Price Surge

Wondering if Axsome Therapeutics at around US$174 a share still offers value, or if most of the opportunity has already been priced in? This article is built to help you frame that question clearly. The stock has seen a 3.9% return over the past week and 18.6% over the last 30 days, while year to date it is at a 2.5% decline and up 85.9% over the last year and 155.9% over three years, with a 129.4% return over five years. Recent coverage of Axsome has focused on its position in...
NYSE:DEI
NYSE:DEIOffice REITs

Is Douglas Emmett (DEI) Now Attractive After Prolonged Share Price Weakness And Office Market Concerns

If you are wondering whether Douglas Emmett is priced attractively today, or if the share price still does not reflect its underlying real estate assets, this article explains what the current market value might be telling you. The stock recently closed at US$10.97, with returns of a 1.6% decline over 7 days, a 4.8% decline over 30 days, a 0.9% decline year to date, a 32.8% decline over 1 year and a 51.5% decline over 5 years. This performance may have changed how investors view its risk and...
NasdaqCM:SLS
NasdaqCM:SLSBiotechs

A Look At SELLAS Life Sciences Group (SLS) Valuation After New IMPACT AML Clinical Collaboration

SELLAS Life Sciences Group (SLS) is back on investor radars after it agreed with the IMPACT AML network to run a European clinical study of its CDK9 inhibitor, SLS009, in high risk newly diagnosed AML. See our latest analysis for SELLAS Life Sciences Group. The new IMPACT AML agreement comes after a volatile spell where traders focused on financing risk, yet the stock still shows a 74.55% 30 day share price return and a very large 1 year total shareholder return. This suggests momentum has...
NYSE:GS
NYSE:GSCapital Markets

Goldman Sachs Group (GS) Earnings Rebound And 27.4% Margin Test Moderate Growth Narratives

Goldman Sachs FY 2025 Earnings Snapshot Goldman Sachs (GS) closed out FY 2025 with fourth quarter revenue of US$15.6 billion and basic EPS of US$14.27 on net income of US$4.4 billion, setting the tone for how investors are reading the latest numbers. Over the past six reported quarters, the bank has seen quarterly revenue move from US$12.3 billion in Q3 2024 to US$13.5 billion in Q4 2024 and then to US$15.6 billion in Q4 2025, while basic EPS shifted from US$8.52 to US$12.14 to US$14.27 over...
NasdaqCM:MREO
NasdaqCM:MREOBiotechs

Why Mereo BioPharma (MREO) Is Up 69.9% After Mixed Setrusumab Phase 3 Results And Pipeline Shift

Mereo BioPharma Group recently reported that its Phase 3 Orbit and Cosmic trials of setrusumab in osteogenesis imperfecta missed their primary fracture reduction endpoints but achieved strong statistical improvements in bone mineral density, while also updating investors that its approximately US$41,000,000 cash balance at 31 December 2025 is expected to fund operations to mid-2027. Alongside reassessing the future of setrusumab with partner Ultragenyx, Mereo is pushing ahead with a single...
NYSE:ALV
NYSE:ALVAuto Components

Is Autoliv (ALV) Attractive After Strong Multi Year Share Price Performance

If you are wondering whether Autoliv’s current share price lines up with its underlying value, this breakdown is designed to walk you through the key numbers that matter. Autoliv shares last closed at US$128.45, with returns of 4.2% over 7 days, 5.9% over 30 days, 5.2% year to date, 36.0% over 1 year and 71.8% over 3 years. This naturally raises questions about how much of this performance is already reflected in the price. Recent attention on Autoliv has centered on its position in vehicle...
NasdaqGS:ROOT
NasdaqGS:ROOTInsurance

Did Cash Strain and a New Kikoff Partnership Just Shift Root's (ROOT) Investment Narrative?

In the past week, digital auto insurer Root faced renewed scrutiny after a Wells Fargo analyst highlighted weakening operating cash flow, reduced available capital, and an underwriting loss reflected in a 102% combined ratio. At the same time, Root Insurance and personal finance platform Kikoff announced an embedded insurance partnership, integrating Root’s data-driven auto policy quoting and purchasing directly into the Kikoff app to broaden access to mobile-first coverage. We’ll now...
NasdaqCM:KOPN
NasdaqCM:KOPNSemiconductor

Can Kopin’s (KOPN) First DarkWAVE Order Redefine Its Defense Microdisplay Positioning?

Kopin Corporation recently announced that Theon International placed a US$1.0 million development order for its 960p DarkWAVE™ module, moving the AR‑ and thermal‑enabled clip‑on night-vision platform from prototype to production readiness for international defense customers in 2026. This first meaningful DarkWAVE order targets the large aftermarket of an estimated more than 2 million fielded night-vision goggles worldwide, potentially turning existing systems into AR-enabled devices without...